BNOS 2017 keynote speaker presentations

Videos by Geoff Cross


 

BNOS 2017 – Wednesday

 Plenary Session 3:  Surgery and Pathology

  • WHO 2016 What has changed?  Kathreena Kurian, University of Bristol


 

  • Decision making in Neurosurgery: Example low grade glioma, Mark Bernstein, University of Toronto, Canada


 

Plenary Session 4:  Best Practice Management

  • Best Seizures Management, Roberta Rudà, University of Turin


 

  • Best Oncological treatment for LGG, Jan Buckner, Mayo Clinic


 

Parallel Session B: Science in Neuro-Oncology

  • Advances in diagnostic and prognostic molecular markers for GliomasSebastian Brandner, University College London


 

  • Microenvironmental signalling in Glioblastoma, Simona Parrinello, Imperial College London


 

  • New experimental tools to identify key therapeutic targets in glioma, Steve Pollard, University of Edinburgh

Please note:  this presentation is currently under embargo and will be made available in the New Year 2018


 

BNOS 2017 – Thursday

Invited speaker

  • Neural stem cell self-renewal: a therapeutic target for glioma, Steve Pollard, University of Edinburgh

Please note:  this presentation is currently under embargo and will be made available in the New Year 2018


 

Sponsored by The Brain Tumour Charity:  Stephen Baker Memorial Lecture

  • Targeting brain cancer stem cells, Peter Dirks, University of Toronto


 

Plenary Session 1:  HGG session

  • Epigenetic targets in cancer, Kristian Helin, University of Copenhagen


 

  • Neuro-Oncology Explored Using Qualitative Research, Mark Bernstein, University of Toronto


 

Plenary Session 2: Paediatrics and TYA

  • The Biology of Medulloblastoma, Steve Clifford, University of Newcastle


 

  • Management of High Risk Medulloblastoma, Simon Bailey, University of Newcastle


 

  • Late Effects on Childhood Cancer patients, Hamish Wallace, University of Edinburgh


 

BNOS 2017 – Friday

Plenary session 3:  Brain Metastases and other tumours

  • Immunotherapy in Brain Metastases, Poulam Patel, University of Nottingham


 

  • Radiotherapy and SRS evidence, Sara Erridge, University of Edinburgh


 

  • Proton Beam Therapy – UK service and application in CNS tumors?  Edward Smith and Gillian Whitfield, The Christie NHS Foundation Trust


 

Plenary Session 4: Clinical Trials

  • NCRI brain CSG trials, Colin Watts, University of Cambridge


 

  • Trial design in LGG and outcomes, Jan Buckner, Mayo Clinic


 

  • Trial design in the elderly and outcomes, James Perry, University of Toronto


 

  • Clinical Radiotherapy Trials in Gliomas, Anthony Chalmers, University of Glasgow